Hypermarcas (OTCMKTS:HYPMY) Sees Large Growth in Short Interest

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 30th, there was short interest totaling 63,443 shares, an increase of 396,418.8% from the April 15th total of 16 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 73,789 shares, the days-to-cover ratio is presently 0.9 days.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy”.

Get Hypermarcas alerts:

Check Out Our Latest Research Report on Hypermarcas

Hypermarcas Stock Performance

OTCMKTS:HYPMY traded down $0.07 during midday trading on Monday, hitting $4.79. The company’s stock had a trading volume of 14,043 shares, compared to its average volume of 22,888. Hypermarcas has a fifty-two week low of $3.71 and a fifty-two week high of $5.50. The firm’s 50 day moving average is $4.44 and its 200-day moving average is $4.50. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84. The firm has a market cap of $3.37 billion, a P/E ratio of 9.97 and a beta of 0.73.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The firm had revenue of $383.13 million for the quarter. Equities analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

Hypermarcas Company Profile

(Get Free Report)

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.

Featured Stories

• Five stocks we like better than Hypermarcas
• Before the Moon Base Gets Built, These 4 Companies Win
• Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
• 3 Stocks That Win If Inflation Surprises to the Downside
• MercadoLibre Boldly Invests in Growth: Discount Deepens

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.